MASTL is enriched in cancerous and pluripotent stem cells and influences OCT1/OCT4 levels
Authors: Elisa Närvä, Maria E. Taskinen, Sergio Lilla, Aleksi Isomursu, Mika Pietilä, Jere Weltner, Jorma Isola, Harri Sihto, Heikki Joensuu, Sara Zanivan, Jim Norman, Johanna Ivaska
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.